KMT2A and acute lymphoblastic leukemia: It is estimated that 4-8% of T-ALL patients harbor a KMT2A gene fusion and given KMT2A fusions are detectible via cytogenetics, a subtype can be readily defined for 1:12-1:25 patients [8, 42, 61].